- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Renegotiating the National Nanotechnology Initiative
Nanotechnology promises to provide new technological solutions for myriad problems in medicine, defense, and public health. With this promise, however, comes a reservation about the safety of the widespread use of nanotechnology. In the United States, the National Nanotechnology Initiative serves as the hub for federal funding and regulation of nanotechnology. After five years of operation, the Senate reviewed progress of the NNI and called it a “model” program for its ability to unite 25 federal agencies. The President’s Council of Advisors on Science and Technology offered similar praises in its April 2008 Second Assessment and Recommendations of the National Nanotechnology Advisory Panel. The panel also advised, among other things:
Expansion of communication and outreach efforts, particularly with respect to real and perceived benefits and risks associated with nanotechnology;
Developing and implementing standards critical for nanomaterial identification, characterization, and risk assessment; and
Coordinating strategically-guided nanotechnology environmental, health, and safety research across agencies, sectors, and countries and including a balanced assessment of risks and benefits in the context of specific, real-world applications.
H.R. 5940, the National Nanotechnology Initiative Amendments Act of 2008, is a step in the right direction to address these issues. The act authorizes the designation of an associate director of the Office of Science and Technology Policy as “the Coordinator for Societal Dimensions of Nanotechnology,” responsible for coordinating, planning, and prioritizing budgets of activities all required by section 2 (b) (10) of the 21st Century National Nanotechnology Research and Development Act of 2003. These activities include: developing an understanding of control and manipulation of particles at the nano scale, providing research grants, establishing a network of advanced technology user facilities and centers, and establishing interdisciplinary nanotechnology research centers.
Where this 2003 act offers a huge set of requirements for ensuring that ethical, societal, and health issues in nanotechnology are addressed, H.R. 5940 articulates a mechanism, the position of the Coordinator for Societal Dimensions of Nanotechnology, by which to fulfill these requirements. The other provisions of H.R. 5940 also provide programs to educate the public about nanotechnology and provide means for assessing the success of the NNI . H.R. 5940 was passed to the Senate and is currently in the hands of the Committee on Commerce, Science, and Transportation. The Senate also received the Nanotechnology in the Schools Act, which would require the director of the National Science Foundation to establish a nanotechnology in the schools program that would fund secondary education in nanotechnology, and passed it to the Committee on Health, Labor, Education, and Pensions.
Comments on this article


